Effect of Abdominal Wall Injections on Abdominal Pain
This is a prospective cohort study of outpatient adults with chronic abdominal wall pain receiving abdominal wall injections, as part of their usual care, with lidocaine. Subjects will be recruited at the outpatient gastroenterology clinic at OHSU.
| Condition(s) | Anterior Cutaneous Nerve Entrapment Syndrome |
|---|---|
| Status | Recruiting |
| Phase | Phase 4 |
| Study type | Interventional |
| Summary | This is a prospective cohort study of outpatient adults with chronic abdominal wall pain receiving abdominal wall injections, as part of their usual care, with lidocaine. Subjects will be recruited at the outpatient gastroenterology clinic at OHSU. |
| Who can participate | Inclusion Criteria: * Localized abdominal wall pain * Average daily pain (7-day recall) ≥ 3 on a scale of 0-10 * Suspected abdominal wall etiology for abdominal pain * Positive Carnett's sign or pain near an incisional site * 18 years of age or older Exclusion Criteria: * Suspected visceral etiology for the abdominal pain * Severe allergy to lidocaine * Unwillingness or inability to provide informed consent * Low probability of follow-up * Abdominal wall hernia noted at the point of pain * History of trigger point injections for abdominal pain * Bleeding disorder * Pregnancy, incarceration or decisionally impaired |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Oregon Health and Science University |
| Locations | Portland, Oregon, United States; Portland, Oregon, United States |
| Start date | 2023-01-01 |
| NCT ID | NCT06121466 |
| Official listing | https://clinicaltrials.gov/study/NCT06121466 |